SpyGlass Pharma, Inc. (SGP): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$98.84M

As of 2025-12-31

$232.36M

As of 2026-06-30

2024-12-31 Shareholders' Equity (USD) 2025-12-31

Period ended	Shareholders' Equity	Change YoY	Source filing
2025-12-31	-$98.84M	n/m	2026-03-26, Balance as of period end
2024-12-31	-$60.47M	n/a	2026-03-26, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Shareholders' Equity	Change YoY
SpyGlass Pharma, Inc. (SGP)	2025-12-31	-$98.84M	n/m
Sight Sciences, Inc. (SGHT)	2025-12-31	$63.94M	-26.9%
Orchestra BioMed Holdings, Inc. (OBIO)	2025-12-31	$53.57M	+62.5%
Fractyl Health, Inc. (GUTS)	2025-12-31	$9.46M	-66.7%
DarioHealth Corp. (DRIO)	2025-12-31	$67.92M	-5.7%
Utah Medical Products Inc (UTMD)	2025-12-31	$119.27M	+1.6%
Iradimed Corp (IRMD)	2025-12-31	$94.62M	+9.0%
Delcath Systems, Inc. (DCTH)	2025-12-31	$111.22M	+61.8%
Alpha Tau Medical Ltd. (DRTS)	2025-12-31	$77.10M	+23.0%

Compare SGP, SGHT, OBIO, GUTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗